Search results
Found 509 matches for
Base Genomics announces the company's launch with $11M to commercialise epigenetic technology for early and sensitive cancer detection from a liquid biopsy.
"We loved being in the BioEscalator, and part of the community, and the support and flexibility from the BioEscalator team was invaluable."
Hollie Coe, Base Genomics (now Exact Sciences Innovation)
"The high-quality facilities, resources and support to grow a company were invaluable."
Tim Funnell, MiroBio (now Gilead)